Date: 2018-05-11
Type of information: Construction of new premises
Compound:
Company: Intralytix (USA - MA)
Therapeutic area: Infectious diseases
Type agreement: construction of new premises
Action mechanism:
Disease:
Details:
- • On May 11, 2018. Intralytix announced that it has closed on the acquisition of a 33,000 sq. ft. building in Columbia, Maryland. The facility, located in the Columbia Gateway Community, will serve as the Company's new headquarters. Plans are underway to house expanded research and laboratory space, executive offices, and substantially increased manufacturing capacity.
=
Financial terms:
Latest news:
Is general: Yes
